Apollomics to present at the h.c. wainwright 25th annual global investment conference

Foster city, calif., sept. 06, 2023 (globe newswire) -- apollomics inc. (“apollomics” or the “company”), a clinical-stage biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today announced that sanjeev redkar, ph.d., co-founder, executive director and president, will present at the h.c. wainwright 25th annual global investment conference on wednesday, september 13, 2023 at 10:30 a.m. et at the lotte new york palace in new york, ny.
APLM Ratings Summary
APLM Quant Ranking